RNAi Screening Libraries
Invitrogen™ Silencer™ Select Human Cancer Genome siRNA Library
The Silencer™ Select Human Cancer Genome siRNA Library contains 1596 Invitrogen™ Silencer Select siRNAs targeting 532 gene targets that are commonly affected in cancers.
Invitrogen™ Silencer™ Human Cell Surface siRNA Library
Cell surface receptors are specialized integral membrane proteins that take part in communication between the cell and its surroundings.
Invitrogen™ Silencer™ Select Human Druggable Genome siRNA Library V4
For the first time, you can obtain the benefits of Ambion™Silencer™ Select siRNAs in a convenient pre-plated, library format.
Thermo Scientific™ Silencer™ siRNA Library, In Plate
Silencer™ siRNA Libraries feature combinations of Silencer™ Pre-designed siRNAs, and when available, Validated siRNAs in 96-well or 384-well plates.
Invitrogen™ Silencer™ Human Genome siRNA Library
The Silencer™ Human Genome siRNA Library contains a total of 65,058 siRNAs targeting 21,686 genes extracted from the NCBI RefSeq database.
Invitrogen™ Silencer™ Select Human Transcription factor siRNA Library
The Silencer Select Human Transcription Factor siRNA Library contains 5457 Invitrogen™ Silencer Select highly potent and chemically-modified siRNAs targeting 1819 known transcription factors.
Invitrogen™ Silencer™ Human Cell Cycle Regulation siRNA Library
Proteins that regulate cell division are crucial for controlling cell growth and are therefore potentially important drug targets.
Invitrogen™ LentiArray™ Human Cell Surface CRISPR Library
The Invitrogen™ LentiArray™ Human Cell Surface Protein Library targets 778 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 3,112 gRNAs. Libraries are delivered as 100 μL of ready to use lentiviral particles per gene target.
Invitrogen™ Silencer™ Human Kinase siRNA Library
Given their importance in cell signaling and many other biological pathways, kinases have become key drug targets.
Invitrogen™ Silencer™ Select Human Tumor Suppressor siRNA Library
Mutations that cause a loss or reduction in gene function can result in the progression to cancer, usually in combination with other genetic changes. Tumor suppressor genes, or anti-oncogenes, can protect cells on the path to becoming cancerous.
Invitrogen™ Silencer™ Human DNA Damage Response siRNA Library
DNA surveillance proteins monitor DNA integrity, and they can activate cell cycle checkpoints and DNA repair pathways in response to DNA damage. This can prevent potentially deleterious mutations.
Invitrogen™ Silencer™ Human Drug Targets siRNA Library (384 well)
The Silencer Human Drug Targets siRNA Library contains 23,745 Invitrogen™ Silencer siRNAs targeting 7,915 genes for performing RNAi screens against known human drug target genes.
Invitrogen™ LentiArray™ Human Nuclear Hormone Receptor CRISPR Library
The Invitrogen™ LentiArray™ Human Nuclear Hormone Receptor Library targets 47 genes with up to 4 gRNA per gene target (pooled in a single well) for a total of 188 gRNAs. Libraries are delivered as 100 μL of ready to use lentiviral particles per gene target.
LentiArray™ Human GPCR Library, Glycerol Stock
Targets 446 genes with up to 4 gRNA per gene target for a total of 1,784 gRNAs. Libraries are delivered as 50μL of glycerol stock per gRNA and are also available as ready to use packaged lentivirus.
LentiArray™ Human Membrane Trafficking Library, Glycerol Stock
Targets 141 genes with up to 4 gRNA per gene target for a total of 564 gRNAs. Libraries are delivered as 50μL of glycerol stock per gRNA and are also available as ready to use packaged lentivirus